NR1I2 Back

nuclear receptor subfamily 1, group I, member 2

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of NR1I2
This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized.

Community Annotation of NR1I2 Add / Edit NR1I2: Annotations

No community annotations yet for NR1I2.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

NR1I2 is highly significantly mutated in
(none)
NR1I2 is significantly mutated in
(none)
NR1I2 is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for NR1I2